SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Date of report (Date of earliest event reported): February 5, 2004
UNITEDHEALTH GROUP INCORPORATED
Minnesota | 0-10864 | 41-1321939 | ||
|
||||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
UnitedHealth Group Center, 9900 Bren Road East, Minnetonka, Minnesota | 55343 | |||
|
||||
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code (952) 936-1300
N/A
Page 1 of 4 Pages
Exhibit Index on Page 4
Item 5. Other Events.
On February 5, 2004, UnitedHealth Group Incorporated (the Company) agreed to sell $250,000,000 principal amount of its 3.75% Notes due February 10, 2009 (the 2009 Notes) and $250,000,000 principal amount of its 4.75% Notes due February 10, 2014 (the 2014 Notes and, together with the 2009 Notes, the Notes), pursuant to an Underwriting Agreement and applicable Pricing Agreement each dated February 5, 2004, among the Company and J.P. Morgan Securities Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and UBS Securities LLC as Representatives of the several Underwriters listed on Schedule 1 of the Pricing Agreement referenced above. The Notes will be issued pursuant to that certain Senior Debt Securities Indenture dated as of November 15, 1998, as amended by an Amendment to Indenture dated as of November 6, 2000, between the Company and The Bank of New York, as Trustee (the Indenture), and a certain Officers Certificate and Company Order dated February 5, 2004, relating to the 2009 Notes, and a certain Officers Certificate and Company Order dated February 5, 2004, relating to the 2014 Notes, each pursuant to Sections 201, 301 and 303 of the Indenture. The Notes have been registered under the Securities Act of 1933, as amended, by a registration statement on Form S-3, File No. 333-105875.
Item 7. Financial Statements and Exhibits.
(c) | Exhibits. | |
1.1 | Underwriting Agreement and applicable Pricing Agreement each dated February 5, 2004, among the Company and J.P. Morgan Securities Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and UBS Securities LLC, as Representatives of the several Underwriters. | |
4.1 | Officers Certificate and Company Order dated February 5, 2004, pursuant to Sections 201, 301 and 303 of the Senior Debt Securities Indenture dated as of November 15, 1998, as amended by Amendment dated as of November 6, 2000, between the Company and The Bank of New York, as Trustee, relating to the 2009 Notes (excluding exhibits thereto). | |
4.2 | Officers Certificate and Company Order dated February 5, 2004, pursuant to Sections 201, 301 and 303 of the Senior Debt Securities Indenture dated as of November 15, 1998, as amended by Amendment dated as of November 6, 2000, between the Company and The Bank of New York, as Trustee, relating to the 2014 Notes (excluding exhibits thereto). | |
4.3 | Specimen of the 2009 Note. | |
4.4 | Specimen of the 2014 Note. |
-2-
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 10, 2004
UNITEDHEALTH GROUP INCORPORATED | ||||
By: | /s/ David J. Lubben | |||
David J. Lubben | ||||
General Counsel & Secretary |
-3-
INDEX TO EXHIBITS
(c) | Exhibits |
1.1 | Underwriting Agreement and applicable Pricing Agreement each dated February 5, 2004, among the Company and J.P. Morgan Securities Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and UBS Securities LLC, as Representatives of the several Underwriters. | |||||
4.1 | Officers Certificate and Company Order dated February 5, 2004, pursuant to Sections 201, 301 and 303 of the Senior Debt Securities Indenture dated as of November 15, 1998, as amended by Amendment dated as of November 6, 2000, between the Company and The Bank of New York, as Trustee, relating to the 2009 Notes (excluding exhibits thereto). | |||||
4.2 | Officers Certificate and Company Order dated February 5, 2004, pursuant to Sections 201, 301 and 303 of the Senior Debt Securities Indenture dated as of November 15, 1998, as amended by Amendment dated as of November 6, 2000, between the Company and The Bank of New York, as Trustee, relating to the 2014 Notes (excluding exhibits thereto). | |||||
4.3 | Specimen of the 2009 Note. | |||||
4.4 | Specimen of the 2014 Note. |
-4-